Latest Breaking News On - Lucilla steinaa - Page 1 : comparemela.com

dusanpetkovic | iStock.com A leading research institute in Kenya has initiated trials to test the efficacy of the first candidate African swine fever vaccines. Key to gaining control over African swine fever (ASF) is the development of an effective vaccine against the disease, according to Lucilla Steinaa of the International Livestock Research Institute (ILRI) of Nairobi. Testing of 10 vaccine candidates has just begun, reports China-based news agency, Xinhua. Efficacy will be evaluated against the virus genotype circulating in central and eastern Africa. At the end of last year, ILRI announced that it had used cutting-edge technology to accelerate the development of ASF vaccines. The technology clustered regularly interspaced short palindromic repeats, CRISPR was being applied to fast-track the development of live-attenuated ASF virus vaccine candidates. Using CRISPR, ILRI scientists had identified the vaccine candidates in a little over one year, while older techniques mig

Kwazulu natalSouth africaNairobi areaFree stateNorth westSouth africanJackie lindenLucilla steinaaInternational livestock research instituteAfrican pork producer associationEuropean commissionWorld organisation for animal healthWorld organisationNorth west provinceSouth african pork producer associationAnimal disease notification system